AG˹ٷ

STOCK TITAN

[Form 4] Septerna, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Septerna, Inc. (SEPN) reported an equity award to Jeffrey Finer, who serves as Chief Executive Officer and a director. The filing shows a grant of a stock option to purchase 210,000 shares of common stock with an exercise price of $11.70 per share and an expiration date of 08/06/2035. The option vests in equal monthly installments equal to 1/48th of the shares, beginning with the monthly anniversary of August 1, 2025, subject to continuous service.

The reported position after the transaction is direct beneficial ownership of the 210,000 options. This disclosure documents a standard long‑term incentive award for the CEO with a multi‑year vesting schedule and a defined exercise price and expiration.

Septerna, Inc. (SEPN) ha comunicato l'assegnazione di un premio azionario a Jeffrey Finer, che ricopre i ruoli di Amministratore Delegato e membro del consiglio. La segnalazione indica una opzione per l'acquisto di 210.000 azioni ordinarie, con prezzo di esercizio di $11,70 per azione e scadenza il 06/08/2035. L'opzione matura in rate mensili uguali corrispondenti a 1/48 delle azioni, a partire dall'anniversario mensile del 1 agosto 2025, subordinatamente alla continuità del servizio.

La posizione riportata dopo l'operazione è la titolarità diretta e beneficiaria delle 210.000 opzioni. La comunicazione documenta un normale incentivo a lungo termine per il CEO, con un piano di maturazione pluriennale e un prezzo di esercizio e una scadenza definiti.

Septerna, Inc. (SEPN) informó la concesión de un premio en acciones a Jeffrey Finer, quien se desempeña como Director Ejecutivo y miembro del consejo. El documento refleja una opción para comprar 210,000 acciones ordinarias con un precio de ejercicio de $11.70 por acción y vencimiento el 06/08/2035. La opción se adquiere en cuotas mensuales iguales equivalentes a 1/48 de las acciones, a partir del aniversario mensual del 1 de agosto de 2025, sujeto a continuidad en el servicio.

Tras la operación, la posición declarada es la tenencia directa y beneficiaria de las 210,000 opciones. Esta divulgación documenta un incentivo estándar a largo plazo para el CEO, con un calendario de adquisición plurianual y un precio de ejercicio y fecha de vencimiento definidos.

Septerna, Inc. (SEPN)� 최고경영� � 이사� Jeffrey Finer에게 주식 보상 지급을 보고했습니다. 신고서에� 보통� 210,000주를 매수� � 있는 스톡옵션� 부여되었으�, 행사가격은 주당 $11.70, 만기일은 2035� 8� 6�� 기재되어 있습니다. 해당 옵션은 근속� 전제� 매월 동일 비율� 1/48� 베스팅되�, 베스팅은 2025� 8� 1�� 월별 기념일부� 시작됩니�.

거래 � 보고� 보유 지위는 해당 210,000 옵션� 직접� 실질 소유입니�. � 공시� CEO에게 지급된 다년간의 베스� 일정� 포함� 표준 장기 인센티브 보상임을 문서화합니다.

Septerna, Inc. (SEPN) a déclaré l'attribution d'une prime en actions à Jeffrey Finer, qui occupe les fonctions de directeur général et d'administrateur. Le dépôt indique une option d'achat de 210�000 actions ordinaires au prix d'exercice de 11,70 $ par action, expirant le 6 août 2035. L'option s'acquiert par fractions mensuelles égales correspondant à 1/48 des actions, à compter de l'anniversaire mensuel du 1er août 2025, sous réserve d'une présence continue en poste.

Après la transaction, la position déclarée est la détention directe et bénéficiaire des 210�000 options. Cette communication décrit une rémunération incitative standard à long terme pour le PDG, avec un calendrier d'acquisition pluriannuel et un prix d'exercice et une date d'expiration définis.

Septerna, Inc. (SEPN) meldete eine Aktienzuteilung an Jeffrey Finer, der als Chief Executive Officer und Direktor tätig ist. Die Einreichung weist eine Option zum Kauf von 210.000 Stammaktien mit einem Ausübungspreis von $11,70 je Aktie und einer Laufzeit bis zum 06.08.2035 aus. Die Option wird in gleichen monatlichen Raten von jeweils 1/48 der Aktien vestiert, beginnend mit dem monatlichen Jahrestag des 1. August 2025, vorbehaltlich durchgehender Dienstzeit.

Nach der Transaktion ist die gemeldete Position die direkte wirtschaftliche Inhaberschaft der 210.000 Optionen. Die Offenlegung dokumentiert eine übliche langfristige Anreizzuteilung für den CEO mit mehrjährigem Vesting‑Plan sowie festgelegtem Ausübungspreis und Ablaufdatum.

Positive
  • Clear alignment with long-term incentives: the option vests over 48 months, encouraging retention and continuity.
  • Transparent terms disclosed: exercise price ($11.70), number of options (210,000), and expiration (08/06/2035) are explicitly reported.
Negative
  • Potential dilution: the grant covers 210,000 underlying shares which could dilute existing shareholders if exercised.
  • Compensation cost: the option grant represents additional executive compensation that may have future accounting and cash tax implications when exercised.

Insights

TL;DR: CEO received 210,000 stock options at $11.70 with 48-month monthly vesting; a typical long-term incentive and retention grant.

The award consists of a stock option covering 210,000 shares with an exercise price of $11.70 and an expiration on 08/06/2035. Vesting is specified as 1/48th per month beginning the monthly anniversary of August 1, 2025, subject to continuous service. From a compensation design perspective, monthly vesting over four years aligns pay with ongoing service and performance period expectations. The grant is recorded as direct beneficial ownership of the options in the filing.

TL;DR: The grant is a routine CEO equity award with clear vesting and term; material only to the extent of dilution and governance oversight.

The Form 4 discloses a direct grant to the CEO of options for 210,000 underlying shares, exercise price $11.70, and expiration 08/06/2035. The explicit monthly vesting schedule (1/48th) and service condition are documented. This filing provides transparency on insider compensation and confirms the reporting person’s ongoing economic interest; it does not by itself indicate unusual governance practices or a change in control.

Septerna, Inc. (SEPN) ha comunicato l'assegnazione di un premio azionario a Jeffrey Finer, che ricopre i ruoli di Amministratore Delegato e membro del consiglio. La segnalazione indica una opzione per l'acquisto di 210.000 azioni ordinarie, con prezzo di esercizio di $11,70 per azione e scadenza il 06/08/2035. L'opzione matura in rate mensili uguali corrispondenti a 1/48 delle azioni, a partire dall'anniversario mensile del 1 agosto 2025, subordinatamente alla continuità del servizio.

La posizione riportata dopo l'operazione è la titolarità diretta e beneficiaria delle 210.000 opzioni. La comunicazione documenta un normale incentivo a lungo termine per il CEO, con un piano di maturazione pluriennale e un prezzo di esercizio e una scadenza definiti.

Septerna, Inc. (SEPN) informó la concesión de un premio en acciones a Jeffrey Finer, quien se desempeña como Director Ejecutivo y miembro del consejo. El documento refleja una opción para comprar 210,000 acciones ordinarias con un precio de ejercicio de $11.70 por acción y vencimiento el 06/08/2035. La opción se adquiere en cuotas mensuales iguales equivalentes a 1/48 de las acciones, a partir del aniversario mensual del 1 de agosto de 2025, sujeto a continuidad en el servicio.

Tras la operación, la posición declarada es la tenencia directa y beneficiaria de las 210,000 opciones. Esta divulgación documenta un incentivo estándar a largo plazo para el CEO, con un calendario de adquisición plurianual y un precio de ejercicio y fecha de vencimiento definidos.

Septerna, Inc. (SEPN)� 최고경영� � 이사� Jeffrey Finer에게 주식 보상 지급을 보고했습니다. 신고서에� 보통� 210,000주를 매수� � 있는 스톡옵션� 부여되었으�, 행사가격은 주당 $11.70, 만기일은 2035� 8� 6�� 기재되어 있습니다. 해당 옵션은 근속� 전제� 매월 동일 비율� 1/48� 베스팅되�, 베스팅은 2025� 8� 1�� 월별 기념일부� 시작됩니�.

거래 � 보고� 보유 지위는 해당 210,000 옵션� 직접� 실질 소유입니�. � 공시� CEO에게 지급된 다년간의 베스� 일정� 포함� 표준 장기 인센티브 보상임을 문서화합니다.

Septerna, Inc. (SEPN) a déclaré l'attribution d'une prime en actions à Jeffrey Finer, qui occupe les fonctions de directeur général et d'administrateur. Le dépôt indique une option d'achat de 210�000 actions ordinaires au prix d'exercice de 11,70 $ par action, expirant le 6 août 2035. L'option s'acquiert par fractions mensuelles égales correspondant à 1/48 des actions, à compter de l'anniversaire mensuel du 1er août 2025, sous réserve d'une présence continue en poste.

Après la transaction, la position déclarée est la détention directe et bénéficiaire des 210�000 options. Cette communication décrit une rémunération incitative standard à long terme pour le PDG, avec un calendrier d'acquisition pluriannuel et un prix d'exercice et une date d'expiration définis.

Septerna, Inc. (SEPN) meldete eine Aktienzuteilung an Jeffrey Finer, der als Chief Executive Officer und Direktor tätig ist. Die Einreichung weist eine Option zum Kauf von 210.000 Stammaktien mit einem Ausübungspreis von $11,70 je Aktie und einer Laufzeit bis zum 06.08.2035 aus. Die Option wird in gleichen monatlichen Raten von jeweils 1/48 der Aktien vestiert, beginnend mit dem monatlichen Jahrestag des 1. August 2025, vorbehaltlich durchgehender Dienstzeit.

Nach der Transaktion ist die gemeldete Position die direkte wirtschaftliche Inhaberschaft der 210.000 Optionen. Die Offenlegung dokumentiert eine übliche langfristige Anreizzuteilung für den CEO mit mehrjährigem Vesting‑Plan sowie festgelegtem Ausübungspreis und Ablaufdatum.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Finer Jeffrey

(Last) (First) (Middle)
C/O SEPTERNA, INC.
250 EAST GRAND AVENUE

(Street)
SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Septerna, Inc. [ SEPN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/07/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $11.7 08/07/2025 A 210,000 (1) 08/06/2035 Common Stock 210,000 $0 210,000 D
Explanation of Responses:
1. 1/48th of the shares subject to such option shall vest and become exercisable in substantially equal monthly installments on each monthly anniversary of August 1, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date.
/s/ Ran Xiao, Attorney-in-Fact 08/11/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Septerna (SEPN) report on the Form 4?

The Form 4 reports a grant of a stock option to CEO Jeffrey Finer to purchase 210,000 shares of common stock.

What is the exercise price and expiration for the options?

The options have an exercise price of $11.70 per share and an expiration date of 08/06/2035.

How and when do the options vest?

Vesting occurs in equal monthly installments of 1/48th of the optioned shares, beginning on the monthly anniversary of August 1, 2025, subject to continuous service.

What is Jeffrey Finer's relationship to Septerna listed in the filing?

The filing identifies Jeffrey Finer as both a Director and the Chief Executive Officer of Septerna, Inc.

How many options does the reporting person beneficially own after the transaction?

The Form 4 reports direct beneficial ownership of 210,000 options following the transaction.
Septerna, Inc.

NASDAQ:SEPN

SEPN Rankings

SEPN Latest News

SEPN Latest SEC Filings

SEPN Stock Data

523.56M
43.38M
2.64%
105.6%
8.4%
Biotechnology
Pharmaceutical Preparations
United States
SOUTH SAN FRANCISCO